Tag: Virpax Pharmaceuticals Inc (NASDAQ: VRPX)

Business

Virpax Pharmaceuticals Inc (NASDAQ: VRPX) Product Pipeline Progress Update

Virpax Pharmaceuticals Inc (NASDAQ: VRPX) aims to become a clinical-stage company as fast as possible. After getting listed in February 2021, the company provides updates or progress on its product pipeline. Working on its goal: Virpax Pharmaceuticals Inc (NASDAQ: VRPX) is steadily working to become a clinical-stage company shortly. Virpax […]